ArticleJournal of thoracic disease2025
Potassium and survival outcomes in asthma patients: evidence from a retrospective cohort study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Asthma is a chronic respiratory disease with multifactorial influences. Although potassium intake has been linked to outcomes in other chronic conditions, its association with all-cause mortality in adults with asthma remains unclear. This study aimed to investigate the association between potassium intake and survival outcomes in patients with asthma. Methods: This retrospective cohort study analyzed data from 6,279 asthma patients in the National Health and Nutrition Examination Survey (NHANES) using weighted methods. Cox proportional hazards regression models were employed to examine the association between potassium and all-cause mortality, with sequential adjustments for demographic characteristics (Model 1), clinical and biochemical factors (Model 2), and comorbidities (Model 3). Kaplan-Meier curves were used to estimate survival probabilities. Subgroup analyses were performed to assess consistency across covariates. Restricted cubic spline (RCS) and threshold analyses were applied to explore non-linear associations and identify intake thresholds. Results: Serum potassium was not significantly associated with all-cause mortality in Models 2 and 3 (P>0.05). In contrast, dietary potassium intake showed a consistent inverse association with mortality across all models. In Model 3, participants in the highest intake quartile had a 37% lower risk of death compared to the lowest quartile [hazard ratio (HR) =0.64; 95% confidence interval (CI): 0.46-0.89; P=0.008]. RCS revealed an inverse relationship, while threshold analysis indicated a reduced mortality risk associated with potassium intake below 3,192 mg/day (HR =0.78; 95% CI: 0.68-0.89; P<0.001). Conclusions: Higher potassium intake was associated with improved survival outcomes in asthma patients, with a threshold effect observed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.